Study of T900607-Sodium in Previously Treated Patients With Ovarian Cancer.

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The purpose of this study is to determine whether T900607-sodium is effective and safe in treating ovarian cancer.

Phase 2

Tularik